AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39

Authors: REGAMEY C ERB P TAMM M CATHOMAS G
Citation: C. Regamey et al., HUMAN-HERPESVIRUS-8 VARIANTS, Lancet, 351(9103), 1998, pp. 680-680

Authors: MORANDI PA SCHOCKMEL GA YERLY S BURGISSER P ERB P MATTER L SITAVANC R PERRIN L
Citation: Pa. Morandi et al., DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA IN POOLSOF SERA NEGATIVE FOR ANTIBODIES TO HIV-1 AND HIV-2, Journal of clinical microbiology, 36(6), 1998, pp. 1534-1538

Authors: REGAMEY N CATHOMAS G SCHWAGER M WERNLI M HARR T ERB P
Citation: N. Regamey et al., HIGH HUMAN-HERPESVIRUS-8 SEROPREVALENCE IN THE HOMOSEXUAL POPULATION IN SWITZERLAND, Journal of clinical microbiology, 36(6), 1998, pp. 1784-1786

Authors: REGAMEY N TAMM M WERNLI M WITSCHI A THIEL G CATHOMAS G ERB P
Citation: N. Regamey et al., TRANSMISSION OF HUMAN-HERPESVIRUS-8 INFECTION FROM RENAL-TRANSPLANT DONORS TO RECIPIENTS, The New England journal of medicine, 339(19), 1998, pp. 1358-1363

Authors: CATHOMAS G STALDER A KURRER MO REGAMEY N ERB P JOLLERJEMELKA HI
Citation: G. Cathomas et al., MULTIPLE-MYELOMA AND HHV8 INFECTION, Blood, 91(11), 1998, pp. 4391-4392

Authors: CATHOMAS G STALDER A REGAMEY N ERB P ITIN PH
Citation: G. Cathomas et al., NO EVIDENCE OF HHV-8 INFECTION IN PATIENTS WITH PEMPHIGUS-VULGARIS FOLIACEUS, Archives of dermatology, 134(9), 1998, pp. 1162-1162

Authors: OPRAVIL M PECHERE M SPEICH R JOLLERJEMELKA HI JENNI R RUSSI EW HIRSCHEL B LUTHY R BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: M. Opravil et al., HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY, American journal of respiratory and critical care medicine, 155(3), 1997, pp. 990-995

Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624

Authors: EGGER M HIRSCHEL B FRANCIOLI P SUDRE P WIRZ M FLEPP M RICKENBACH M MALINVERNI R VERNAZZA P BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W GROB P GRUNINGER U JEANNEROD L LEDERGERBER B LUTHY R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RUTSCHMANN O ZANETTI G
Citation: M. Egger et al., IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY, BMJ. British medical journal, 315(7117), 1997, pp. 1194-1199

Authors: TIETZ A SPONAGEL L ERB P BUCHER H BATTEGAY M ZIMMERLI W
Citation: A. Tietz et al., EOSINOPHILIA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, European journal of clinical microbiology & infectious diseases, 16(9), 1997, pp. 675-677

Authors: LOW N PFLUGER D EGGER M BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B JEANNEROD L LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: N. Low et al., DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS, AIDS, 11(9), 1997, pp. 1165-1171

Authors: NEWELL ML RUDIN C DUNN D PECKHAM C GIAQUINTO C RUGA E DEROSSI A TRUSCIA D GROSCHWORNER I SCHAFER A MOK J JOHNSTONE F JIMINEZ J DEALBA C OMENACATERES F GARCIARODRIGUEZ MC BATES I DEJOSE I HAWKINS F ZAPICO RM CANOSA CA GONZALEZMOLINA A BONET FA SCHERPBIER H BOER K BOHLIN AB LINDGREN S EHRNST A ANZEN B BELFRAGE E LEVY J ALIMENTI A BARLOW P FERRAZIN A DEMARIA A GOTTA C",MARITATI,"MUR A PUGES MTR COLL O FORTUNY C BOGUNA J CARO MC CANET Y PARDI G RAVIZZA M SEMPRINI E CASTAGNA C FIORE S GUERRA B DALLACASA P BIANCHI S BOVICELLI L PRATI E ZANELLI S DUSE M SORESINA A SCARAVELLI G STEGAGNO M DESANTIS M MUGGIASCA ML MARCHISIO P IASCI A SPINILLO A BUCCERI A GROSSI E RANCILIO L CAMLI C SCHNURIGER H WEISSER M KULLY C BERGER R SCHAAD UB DESLEX N PAVIC N BIZER J SCHNEGG M SCHWENDKE A ERB P TICHELLI A BIEDERMANN K LAUPER U ZURRER M KHAN G FIERZ W JOLLER HI IRION O BRUNELLI AP PERRIN L YERLI S SPOLETINI G CHAVE JP SCHREYER A ISENSCHMID M MATHEZIOIC F OTT C DRACK G KELLER K ETIENNETURCHI M SAURENMANN E HELLER S PALY T PASSWER D HEINZL S KNOTEK K SPIRA JC HOLLINGER B SCHNEIDER W SPRENG M DAHLER R STAMM H DELALOYE M SAURINA A FLEISCHMANN R FROHLICHER J GROB B PALY T LEUPPI R WENK B LIMMACHER F HUBER S BRASCHLER C CORNU P GERRETSEN G AFFENTRANGER P POORBEIK M KIND C
Citation: Ml. Newell et al., IMMUNOLOGICAL MARKERS IN HIV-INFECTED PREGNANT-WOMEN, AIDS, 11(15), 1997, pp. 1859-1865

Authors: LORENZI P YERLY S ABDERRAKIM K FATHI M RUTSCHMANN OT VONOVERBECK J LEDUC D PERRIN L HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: P. Lorenzi et al., TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR, AIDS, 11(12), 1997, pp. 95-99

Authors: DIAMANTIS I BASSETTI S ERB P LADEWIG D GYR K BATTEGAY M
Citation: I. Diamantis et al., HIGH PREVALENCE AND COINFECTION RATE OF HEPATITIS-G AND HEPATITIS-C INFECTIONS IN INTRAVENOUS DRUG-ADDICTS, Journal of hepatology, 26(4), 1997, pp. 794-797

Authors: BUECHNER SA WERNLI M HARR T HAHN S ITIN P ERB P
Citation: Sa. Buechner et al., REGRESSION OF BASAL-CELL CARCINOMA BY INTRALESIONAL INTERFERON-ALPHA TREATMENT IS MEDIATED BY CD95 (APO-1 FAS)-CD95 LIGAND-INDUCED SUICIDE/, The Journal of clinical investigation, 100(11), 1997, pp. 2691-2696

Authors: THULBORN KR DAVIS D ERB P STROJWAS M SWEENEY JA
Citation: Kr. Thulborn et al., CLINICAL FMRI - IMPLEMENTATION AND EXPERIENCE, NeuroImage, 4(3), 1996, pp. 101-107

Authors: LAUCHLI S HEUSSER R TSCHOPP A GUTZWILLER F HORNUNG R TWISSELMANN W RUFLI T ERB P RUTTIMANN S GILLI L HIRZ W WILLI B MALINVERNI R VONOVERBECK J MATTER L DEWECK A SCHOEP M HIRSCHEL B PERRIN L DELESDERRIER JC FRANCIOLI P FREI PH CHAVE JP FLEURY F LUTHY R GROB P OPRAVIL M GABERELL H
Citation: S. Lauchli et al., SAFER SEX BEHAVIOR AND ALCOHOL-CONSUMPTION, Annals of epidemiology, 6(4), 1996, pp. 357-364

Authors: SUDRE P HIRSCHEL B TOSCANI L LEDERGERBER B RIEDER HL BATTEGAY M ERB P MALINVERNI R MATTER L PICHLER WJ PERRIN L FREI P VONOVERBECK J FIERZ W VERNAZZA P LUTHY R GROB PJ FRANCIOLI P KNOPFLI D MEISTER T
Citation: P. Sudre et al., RISK-FACTORS FOR TUBERCULOSIS AMONG HIV-INFECTED PATIENTS IN SWITZERLAND, The European respiratory journal, 9(2), 1996, pp. 279-283

Authors: DIAMANTIS I BASSETTI S ERB P LADEWIG D GYR K BATTEGAY M
Citation: I. Diamantis et al., HEPATITIS-G VIRUS IN HCV INFECTED IV DRUG-ADDICTS - HIGH PREVALENCE BUT NO INFLUENCE ON HEPATITIS OUTCOME, Hepatology, 24(4), 1996, pp. 405-405

Authors: VANDELDEN C GABRIEL V SUDRE P FLEPP M VONOVERBECK J HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: C. Vandelden et al., REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS, AIDS, 10(5), 1996, pp. 509-513

Authors: GEHRI R HAHN S ROTHEN M STEUERWALD M NUESCH R ERB P
Citation: R. Gehri et al., THE FAS RECEPTOR IN HIV-INFECTION - EXPRESSION ON PERIPHERAL-BLOOD LYMPHOCYTES AND ROLE IN THE DEPLETION OF T-CELLS, AIDS, 10(1), 1996, pp. 9-16

Authors: BOGGIAN K FIERZ W VERNAZZA PL BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: K. Boggian et al., INFREQUENT DETECTION OF LIPOARABINOMANNAN ANTIBODIES IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MYCOBACTERIAL DISEASE, Journal of clinical microbiology, 34(7), 1996, pp. 1854-1855

Authors: YERLY S RAKIK A KINLOCHDELOES S ERB P VERNAZZA P HIRSCHEL B PERRIN L
Citation: S. Yerly et al., PREVALENCE OF TRANSMISSION OF ZIDOVUDINE- RESISTANT VIRUSES IN SWITZERLAND, Schweizerische medizinische Wochenschrift, 126(43), 1996, pp. 1845-1848

Authors: GALETTOLACOUR A YERLY S PERNEGER TV BAUMBERGER C HIRSCHEL B PERRIN L BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: A. Galettolacour et al., PROGNOSTIC VALUE OF VIREMIA IN PATIENTS WITH LONG-STANDING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 173(6), 1996, pp. 1388-1393

Authors: ROSENBERG D SWEENEY J GILLEN J CHANG S VARANELLI M OHEARN K ERB P DAVIS D THULBORN K
Citation: D. Rosenberg et al., SIMULATION FOR DESENSITIZATION OF CHILDREN REQUIRING MRI, Biological psychiatry, 39(7), 1996, pp. 557-557
Risultati: 1-25 | 26-39